Mark F. Weiss[email protected]Practice ManagementNew codes drive growth for interventional surgical centersThe rapid expansion of billing codes that enable interventional radiology ambulatory surgical centers to collect for outpatient interventional procedures has brought, and will continue to bring, expanding opportunities for interventional radiologists and their groups to profit from ownership of these facilities.December 11, 2017EconomicsA new strategy to profit from interventional radiologyA confluence of trends has created a new business opportunity for interventional radiologists: profiting from the ownership of interventional radiology ambulatory surgery centers. In this article, Mark Weiss and Cecilia Kronawitter discuss this evolving new trend.May 22, 2016Practice ManagementThe Profit Center: Part 26 -- Radiology and the 'me-we' cycleSociety today is becoming increasingly affected by "we" think, from notions of shared sacrifice, to paying your fair share, to "giving back," says healthcare business and legal affairs expert Mark Weiss. Learn how your group should navigate today's environment in this edition of the Profit Center.November 13, 2012EconomicsThe Profit Center: Part 25 -- How safe is hospital employment?In this latest Profit Center installment, healthcare business and legal affairs expert Mark Weiss discusses hospital employment for radiologists, and whether it's really the "safe" career option it's being pitched to be.May 10, 2012Practice ManagementThe Profit Center: Part 24 -- Shadow your competitionIn this latest Profit Center installment, healthcare business and legal affairs expert Mark Weiss discusses how to uncover weaknesses in your contracts and relationships -- before your competitors do it for you.February 16, 2012Practice ManagementThe Profit Center: Part 23 -- Strategies for exclusive contractingIn these turbulent times, it is more important than ever to strategically approach the way in which exclusive contracting and group structure and functions are intertwined. To simply keep on keeping on, thinking business success will follow, is folly, says healthcare business and legal affairs expert Mark Weiss.January 29, 2012Practice ManagementThe Profit Center: Part 22 -- Radiology in a communal societySociety is in a collectivistic stage, favoring notions of shared sacrifice over rugged individualism, says healthcare business and legal affairs expert Mark Weiss. When hospitals look to take advantage of the current climate, how can radiology groups protect themselves?December 22, 2011EconomicsThe Profit Center: Part 21 -- Scenarios can shape group strategyRadiology practices often view operational concerns with a focus on current issues. But to be successful, group leaders must imagine what might be, attempting to predict future -- sometimes catastrophic -- events and trends, says healthcare business and legal affairs expert Mark Weiss.August 23, 2011EconomicsThe Profit Center: Part 20 -- The pitfalls of fair market valuationThe fair market valuation process is often unfair, blind to value, and generally ignores the true market, says healthcare business and legal affairs expert Mark Weiss. Learn how to fight for "fair" in agreements between radiology groups and hospitals in this latest installment.June 2, 2011Practice ManagementThe Profit Center: Part 19 -- How to shield against 'weaponized' RFPsIn a quest to get more for less, more hospitals are using a "weaponized" form of the request for proposal (RFP), designed to get a group to grovel for the continuation of its contract, says healthcare business and legal affairs expert Mark Weiss.March 16, 2011Page 1 of 3Next PageTop StoriesClinical NewsBody composition analysis, MRI safety topped 2024's most read articlesWhile COVID and radiology salaries hit the top of AuntMinnie.com's Top 10 most-read posts of 2023, they rounded out the bottom of this year's list.Practice ManagementNeiman index outperforms Charlson for predicting imaging useWomens Imaging40% of women in their 40s forgo biennial breast cancer screeningRisk ManagementPractices must comply with the Corporate Transparency ActNuclear MedicineKidneys appear to tolerate Lu-177 treatments